Effect of Simvastatin on Plasma Homocysteine Levels and Its Modification by MTHFR C677T Polymorphism in Chinese Patients with Primary Hyperlipidemia | |
Xu, Xiping; Zhong, Guisheng; Chen, Qianru; Xing, Houxun; Jiang, Shanqun; Hsu, Yi-Hsiang; Wang, Xiaobin; Venners, Scott A. | |
刊名 | CARDIOVASCULAR THERAPEUTICS
![]() |
2013 | |
卷号 | Vol.31 No.4页码:E27-E33 |
关键词 | Homocysteine MTHFR C677T Polymorphism Primary hyperlipidemia Simvastatin |
ISSN号 | 1755-5914 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2201878 |
专题 | 安徽大学 |
作者单位 | 1.Childrens Mem Res Ctr, Chicago, IL USA [ 10 ] Univ Illinois, Chicago Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA 2.Harvard Univ, Sch Publ Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA 3.Harvard Univ, Sch Med, Boston, MA USA 4.Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA 5.HSL, Inst Aging Res, Boston, MA USA 6.Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China 7.Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada 8.Childrens Mem Hosp, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL 60614 USA 9.Anhui Med Univ, Inst Biomed, Hefei, Peoples R China |
推荐引用方式 GB/T 7714 | Xu, Xiping,Zhong, Guisheng,Chen, Qianru,et al. Effect of Simvastatin on Plasma Homocysteine Levels and Its Modification by MTHFR C677T Polymorphism in Chinese Patients with Primary Hyperlipidemia[J]. CARDIOVASCULAR THERAPEUTICS,2013,Vol.31 No.4:E27-E33. |
APA | Xu, Xiping.,Zhong, Guisheng.,Chen, Qianru.,Xing, Houxun.,Jiang, Shanqun.,...&Venners, Scott A..(2013).Effect of Simvastatin on Plasma Homocysteine Levels and Its Modification by MTHFR C677T Polymorphism in Chinese Patients with Primary Hyperlipidemia.CARDIOVASCULAR THERAPEUTICS,Vol.31 No.4,E27-E33. |
MLA | Xu, Xiping,et al."Effect of Simvastatin on Plasma Homocysteine Levels and Its Modification by MTHFR C677T Polymorphism in Chinese Patients with Primary Hyperlipidemia".CARDIOVASCULAR THERAPEUTICS Vol.31 No.4(2013):E27-E33. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论